Why Only 4 in 10 Indians See Big Weight-Loss Results

Weight-loss injections are gaining popularity across India, often positioned as a simple and effective solution for obesity. But only 4 in 10 Indians See Big Weight-Loss Results.

A study conducted at Max Super Speciality Hospital, involving 150 overweight and obese adults, found that only 40 percent of patients achieved at least 10 percent weight loss, a benchmark considered clinically meaningful.

While the drugs are clearly effective, the results fall short of the sweeping expectations built around them.

The study also showed that outcomes are far from uniform. Factors such as diabetes, age, metabolism, and treatment adherence significantly influenced results.

Patients without diabetes lost substantially more weight, while those who combined medication with lifestyle changes performed better overall. Even as newer drugs like tirzepatide showed faster progress compared to semaglutide, experts noted that medication alone was not enough to guarantee success.

At the same time, the findings highlight a broader shift in obesity treatment in India. Weight-loss injections are moving from being seen as optional therapies to becoming part of mainstream medical care. However, the data reinforces a key point: these drugs support weight loss, but they do not replace the need for sustained lifestyle changes.

Also Read: How Semaglutide Works: The Breakthrough Weight-Loss Drug

Key Data & Findings

• 40 percent of patients lost ≥10 percent body weight
• 75 percent of patients lost ≥5 percent body weight
• Average weight loss: ~8 percent in 6 months
• Time to 10 percent weight loss: ~9–10 months
• Study sample size: 150 patients

What Drives the Variation

• Patients without diabetes lost nearly 2x more weight
• Younger individuals responded better to treatment
• First-time users showed stronger results
• Insulin resistance reduced effectiveness
• Consistency in diet and activity improved outcomes

Drug Comparison Insights

• Tirzepatide: Faster and slightly higher weight loss
• Semaglutide: Effective but slower
• Difference between drugs less impactful than lifestyle factors

Real-World vs Clinical Trials

• Real-world average: ~8 percent weight loss (6 months)
• Clinical trials: ~7 percent to 20 percent+ weight loss under ideal conditions
• Gap driven by adherence, lifestyle, and monitoring differences

What This Means

Weight-loss injections are proving effective, but the results are not the same for everyone. Most users experience moderate weight loss rather than dramatic change, with only a smaller group achieving major reductions.

The outcomes are shaped not just by the drug, but by a mix of biology and behavior, including metabolism, underlying health conditions, and daily habits. Overall, the findings point to a clear shift in obesity care, where medical treatment is increasingly being used alongside lifestyle changes rather than replacing them.